Abitate U 250 Mg Tablet (Abiraterone Acetate)
$628.00 – $1,744.68Price range: $628.00 through $1,744.68RxRequired
-
United States dollar ($) - USD
-
Euro (€) - EUR
-
Canadian dollar ($) - CAD
| Pack Size | Price | Unit Price | Quantity | |
|---|---|---|---|---|
| 120 Tablet/s | $628.00 | $5.23 / tablet | ||
| 240 Tablet/s | $1,193.90 | $4.97 / tablet | ||
| 360 Tablet/s | $1,744.68 | $4.85 / tablet |
Add $199.00 to cart and get free shipping!
About Abitate U 250 Mg Tablet (Abiraterone Acetate)
Medicine information
- Indication
- Metastatic castration-resistant prostate cancer (mCRPC). The manufacturer's product information specifically lists Abitate U for mCRPC.
- Strength
- 250 mg
Medicine overview
Abitate U 250 mg Tablet contains abiraterone acetate, an androgen-biosynthesis inhibitor used in the treatment of metastatic castration-resistant prostate cancer. Abiraterone blocks CYP17, an enzyme involved in producing androgens such as testosterone. Lowering androgen production can reduce hormonal stimulation of prostate cancer cells. Treatment with abiraterone is normally combined with a corticosteroid such as prednisone or prednisolone and forms part of a medically supervised prostate-cancer treatment plan.
What it is used for
Abitate U is indicated by its manufacturer for metastatic castration-resistant prostate cancer, meaning prostate cancer that has spread beyond the prostate and continues to progress despite treatments that lower androgen levels. Abiraterone therapy is used with prednisone or prednisolone. Patients who have not undergone surgical removal of the testes generally continue medical androgen-deprivation treatment while receiving abiraterone.
How it works
Abiraterone acetate is converted in the body to abiraterone. It inhibits CYP17, an enzyme required for androgen production in the testes, adrenal glands and prostate tumour tissue. Androgens such as testosterone can stimulate the growth of many prostate cancers. By reducing androgen production, abiraterone lowers this hormonal stimulation and can help slow progression of androgen-dependent prostate cancer. Blocking CYP17 also affects corticosteroid hormone production, which is why treatment is normally given with prednisone or prednisolone.
How it is taken
Take Abitate U exactly as prescribed. Abiraterone tablets are taken by mouth on an empty stomach with water. Do not eat for at least 2 hours before taking the medicine or for at least 1 hour afterward because food can substantially increase abiraterone exposure. Swallow the tablets whole and do not crush or chew them. Do not stop abiraterone or the accompanying corticosteroid without medical advice.
Important warnings
Abiraterone can cause high blood pressure, low blood potassium and fluid retention; these risks require particular care in people with heart failure, cardiovascular disease or abnormal heart rhythms. Severe liver injury, including acute liver failure, has been reported, and treatment is not recommended in patients with severe baseline liver impairment. Adrenal insufficiency may occur, especially if the accompanying corticosteroid is interrupted or during illness or severe stress. Abiraterone with prednisone or prednisolone should not be combined with radium Ra 223 because of increased fracture and mortality risk. Strong CYP3A4 inducers should generally be avoided, and abiraterone can affect medicines metabolised by CYP2D6 and CYP2C8. Severe hypoglycaemia has occurred in patients with diabetes taking medicines such as pioglitazone or repaglinide. Seek urgent medical attention for severe allergic reactions, fainting, marked shortness of breath, serious heart-rhythm symptoms or signs of severe liver injury such as jaundice and dark urine.
Side effects and monitoring
Common effects include fatigue, joint discomfort, high blood pressure, nausea, swelling or fluid retention, low potassium, hot flushes, diarrhoea, vomiting, cough and headache. Serious or less common problems include severe liver injury, adrenal insufficiency, significant hypokalaemia, heart-rhythm disturbances, severe allergic reactions, muscle injury and severe hypoglycaemia in susceptible patients. Blood pressure, potassium and signs of fluid retention should be monitored at least monthly. Liver tests are generally checked before treatment, every 2 weeks for the first 3 months and monthly thereafter, with additional monitoring when clinically required.
Pregnancy
Abiraterone can harm a developing fetus and is not intended for use in women. Women who are pregnant or may become pregnant should not handle broken, crushed or damaged abiraterone tablets without protection such as gloves. Male patients with female partners who can become pregnant should use effective contraception during treatment and for 3 weeks after the final dose.
Breastfeeding
Abiraterone is not indicated for use in women. It is not known whether abiraterone is present in human milk or what effects it may have on a breastfed child or milk production.
Food and drink
Take abiraterone on an empty stomach. Do not eat for at least 2 hours before the dose or for at least 1 hour afterward. Food can cause a large and unpredictable increase in abiraterone exposure, which may increase the risk of adverse effects. Swallow the tablet with water.
Frequently asked questions
Why does abiraterone have to be taken on an empty stomach?
Food can greatly and unpredictably increase the amount of abiraterone absorbed into the bloodstream. Take it at least 2 hours after food and do not eat for at least 1 hour afterward.
Why is prednisone or prednisolone used with abiraterone?
Abiraterone suppresses CYP17 and can alter normal corticosteroid hormone production. The prescribed corticosteroid helps reduce complications associated with this hormonal effect and should not be stopped without medical advice.
Can abiraterone cause fatigue or swelling?
Yes. Fatigue and peripheral oedema or fluid retention are recognised adverse effects. New or worsening swelling, rapid weight gain or shortness of breath should be reported because fluid retention can be more significant in people with cardiovascular disease.
What monitoring is needed while taking abiraterone?
Blood pressure, blood potassium and signs of fluid retention should be checked regularly, generally at least monthly. Liver-function blood tests are also required before and during treatment, with closer monitoring early in therapy.
What should I do if I miss a dose of abiraterone?
If one dose is missed, take the usual prescribed dose the next day. If more than one dose is missed, contact the prescribing doctor rather than taking extra tablets.
Can abiraterone affect the liver?
Yes. Abiraterone can cause significant liver-enzyme elevations and, rarely, severe liver injury. Contact a healthcare professional promptly for yellow skin or eyes, dark urine, severe nausea or vomiting, unusual tiredness or loss of appetite.
Can abiraterone be taken with radium Ra 223?
The combination of abiraterone plus prednisone or prednisolone with radium Ra 223 is not recommended because clinical studies found an increased risk of fractures and death.
Is Abitate U 250 mg Tablet a prescription medicine?
Yes. Abiraterone is a prescription anticancer medicine and treatment requires medical supervision and ongoing monitoring.
Sources
Medical information notice: This information does not replace advice from a qualified healthcare professional. Use prescription medicine only as directed by the prescriber and the approved product information.
| Active Ingredients | Abiraterone Acetate |
|---|---|
| Manufacturer | RPG Life Sciences Ltd. |
| Packaging | Qty |
| strength | 250mg |
| Delivery Time | 6 To 15 days |

Reviews
There are no reviews yet.